JUL 22, 2019 5:43 AM PDT

How to Kill Superbugs

WRITTEN BY: Amanda Mikyska

Researchers at The University of Tokyo and Teikyo University Institute of Medical Mycology, have synthesized three synthetic antibiotics effective in killing superbugs, which typically resistance to antibiotic treatment.  The method used to synthesize the new antibiotic candidates, called "one bead one compound," comes from biological research in creating many unique peptides.  By adopting this approach, the researchers were able to mimic a natural antibiotic of superbugs with thousands of synthetic molecules and decrease research time.  

Organisms like methicillin-resistant Staphylococcus aureus (MRSA) first developed a resistance to the antibiotic vancomycin, developed in the 1950s.  However, resistance to vancomycin has increased dramatically in recent years, by MRSA and other pathogens.  Lysocin e, a natural antibiotic isolated from soil in southwestern Japan, proved to be ten times more effective at killing drug-resistant bugs.  However, superbugs can easily resist two different antibiotic treatments, so the researchers in Tokyo aimed to synthesize a better version of lysocin e. 

Image: Centers for Disease Control and Prevention

 

Lysocin E is a large ring-shaped molecule with 12 side chains.  The "one bead one compound" method creates variations of the structural components that make up lysocin e, then the original elements by the variants one at a time.  This process resulted in over 2400 versions of a lysocin e analogs, all unique synthesized at the same time.  Candidates that could not kill MRSA at all were eliminated first.  Of the 22 remaining candidates, only half were equal or more effective than lysocin e.  Now, the top three candidates are being investigated for further.  

Antibiotic resistance is a significant public health concern, affecting more than 2 million people in the U.S. every year, according to the Centers for Disease Control and Prevention (CDC).  The "one bead one compound" method of producing drug candidates could dramatically cut research time and result in more powerful antibiotics.

 

Sources:  Nature, Centers for Disease Control and Prevention (CDC), TechnologyNetworks

About the Author
  • Amanda graduated for the University of Massachusetts Boston with a degree in Biology. After working in research on creating biochemicals from genetically engineered yeast, she started freelance science writing while traveling the world. She writes about the latest research in Neuroscience, Genetics & Genomics, and Immunology. Interested in working on solutions for food/water security, sustainable fuel, and sustainable farming. Amanda is an avid skier, podcast listener, and has run two triathlons.
You May Also Like
SEP 29, 2019
Drug Discovery & Development
SEP 29, 2019
Researchers Can Now Reverse Skin Cancer
Ten years ago, just 5% of people with advanced melanoma (skin cancer) lived more than five years after being diagnosed. Now however, researchers from the I...
NOV 01, 2019
Immunology
NOV 01, 2019
Immunity to HPV Can Prevent Skin Cancer
Scientists discovered a surprise benefit of low-risk human papillomaviruses (HPV), a typical resident of human skin. New research shows that these harmless...
NOV 03, 2019
Genetics & Genomics
NOV 03, 2019
Can CRISPR Replace Antibiotics?
Antibiotic-resistant infections claim around 700,000 lives per year, with estimates saying that this number could swell to 10 million by 2050 (Jacobs: 2019...
NOV 12, 2019
Immunology
NOV 12, 2019
Allergy Shots May Work for Kids with Pollen Food Allergy Syndrome
It’s not common for young children to develop pollen food allergy syndrome (PFAS), but for those that do, there’s not too much parents can do o...
NOV 13, 2019
Health & Medicine
NOV 13, 2019
Antibiotic Resistance by the Numbers
The Centers for Disease Control and Prevention (CDC) just released its latest Antibiotic Threats in the United States report, which is summarized in the vi...
NOV 28, 2019
Drug Discovery & Development
NOV 28, 2019
Immunotherapy Drug Shows Promise for Treating Advanced Prostate Cancer
By the end of the year, an estimated 175,000 men in the United States will have been diagnosed with prostate cancer. Now, researchers from the UK have foun...
Loading Comments...